Archives

Alan Hinman, MD, MPH, Consulting Advisor at The Task Force’s Center for Vaccine Equity and part of the PIVI Strategic Advisory Group recently received the prestigious Dr. Charles Mérieux Award [...]

“Despite global recommendations for influenza vaccination of high-risk, target populations, few low and middle-income countries have national influenza vaccination programs. Between 2012 [...]

2018 was a year of growth for PIVI, as new countries joined the partnership and existing partner countries moved toward achieving stable influenza vaccine programs. Learn more about our impact [...]

WHO lists a Global Influenza Pandemic as one of ten important health issues that will demand attention from WHO and health partners in 2019.

“Influenza vaccination is a key public health intervention for pandemic influenza as it can limit the burden of disease, especially in high-risk groups, minimize social disruption and [...]

In 2014 the Kenya National Immunization Technical Advisory Group (KENITAG) was asked by the Ministry of Health to provide an evidence-based recommendation on whether the seasonal influenza [...]

Due to competing health priorities, low- and middle-income countries (LMIC) may need to prioritize between different influenza vaccine risk groups. Risk group prioritization may differ in LMIC [...]

Charlie Hinderliter wasn’t opposed to the flu shot. He didn’t have a problem with vaccinations. He was one of about 53 percent of Americans who just don’t get one. “I figured [the flu] was [...]

“What would surprise people about the flu? The fact that it kills even young, healthy people who don’t have other risk factors, said Dr. Joe Bresee, just before opening a public symposium [...]

“One hundred years ago, death came with astonishing speed and horrifying agony. Some influenza patients admitted to a Boston hospital in the morning of October 1918 would be dead by the [...]